Related Experiment Videos

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics

Insights

Rifampin demonstrated the highest activity against both Staphylococcus aureus and Staphylococcus epidermidis. Susceptibility testing revealed varying efficacy among different antibiotic classes for these common bacteria.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococcus aureus and Staphylococcus epidermidis are significant human pathogens.
  • Antimicrobial resistance necessitates ongoing surveillance of bacterial susceptibility patterns.

Purpose of the Study:

  • To evaluate the in vitro activity of a broad spectrum of antimicrobial agents against recent clinical isolates of S. aureus and S. epidermidis.
  • To compare the efficacy of individual agents and combinations.

Main Methods:

  • Susceptibility testing of 36 S. aureus and 35 S. epidermidis isolates.
  • Evaluation against 65 individual antimicrobial agents and selected combinations.
  • Determination of minimal inhibitory concentrations (MICs).

Main Results:

  • Rifampin exhibited the highest overall activity against both species.
  • Cloxacillin, dicloxacillin, and nafcillin were the most potent penicillins; cephaloridine and sisomicin were the most active cephalosporin and aminoglycoside, respectively.
  • Minocycline was superior among tetracyclines, and clindamycin among macrolide-lincomycin compounds. Trimethoprim-sulfamethoxazole showed notable synergy against S. aureus.

Conclusions:

  • Rifampin is a highly effective agent against contemporary S. aureus and S. epidermidis isolates.
  • Differential susceptibility patterns exist between S. aureus and S. epidermidis for certain antibiotic classes, influencing treatment choices.

Related Concept Videos